Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04914312 · ClinicalTrials.gov registry record · NA
Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT04914312 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 32 participants.
The verdict
NCT04914312, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine the effect of maqui extract plus omega-3 fatty acids compared to a placebo for reducing inflammatory cytokine levels in older, obese adults.
Interventions
- DIETARY_SUPPLEMENT Placebos
- DIETARY_SUPPLEMENT Maqui berry/omeg-3 fatty acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-01-15 |
| Est. Completion | 2023-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04914312
The ClinicalTrials.gov registry entry for NCT04914312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT04914312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04914312 about?
NCT04914312 is a clinical study titled "Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction". The purpose of this trial is to determine the effect of maqui extract plus omega-3 fatty acids compared to a placebo for reducing inflammatory cytokine levels in older, obese adults.
What is the current status of trial NCT04914312?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-01-15. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT04914312?
The interventions under investigation include: Placebos (DIETARY_SUPPLEMENT), Maqui berry/omeg-3 fatty acids (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04914312?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.